Skip to main content
. 2022 Aug 26;2022:7743705. doi: 10.1155/2022/7743705

Figure 3.

Figure 3

Monosialotetrahexosyl ganglioside-incorporated reconstituted high-density lipoprotein (GM1-rHDL) possesses antibody-like high binding affinity to Aβ, facilitates Aβ degradation by microglia and Aβ efflux across the blood-brain barrier (BBB), and simultaneously allows the efficient loading of neuroprotective agents, serving as a nanoparticulate drug delivery system for the combination therapy of AD [155].